ARQL Stock Jumps to 12-Year High On Encouraging ARQ 531 Data
ARQL stock is having an impressive run on the market today after ArQule, Inc. (NASDAQ:ARQL) announced encouraging data from the Phase 1 trial of ARQ 531, its investigational cancer product. About Today’s Development In this regard, ... [Read]